Skip to main content
Premium Trial:

Request an Annual Quote

ServiceXS Certified as Illumina Genotyping Provider

NEW YORK (GenomeWeb News) – Dutch proteomics and genomics services firm ServiceXS said this week that it has completed Illumina CSPro certification for Infinium genotyping, enabling the firm to join Illumina’s global network of genomics services providers.
 
In order to be certified as an Illumina CSPro provider, ServiceXS underwent a two-phase certification process that included minimum data generation, data certification, and an on-site audit of its facilities and processes.
 
ServiceXS said that it intends to complement the genotyping certification with certification for other Illumina technologies.

Filed under

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.